Product
EU-Prolia®
2 clinical trials
2 indications
Indication
Healthy Male VolunteersIndication
Healthy ParticipantsClinical trial
A Randomised, Parallel, Single-Dose, Subcutaneous Injection, Phase I Clinical Study Of HLX14 Versus Prolia® (Denosumab) In Chinese Healthy Adult Male Subjects For Comparison In Pharmacokinetic Characteristics, Safety, And ImmunogenicityStatus: Completed, Estimated PCD: 2023-09-12
Clinical trial
A Randomized, Double-blind, Controlled, Parallel-group, Single Dose, Three-arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Versus Prolia® Sourced From the European Union and United States in Healthy Male ParticipantsStatus: Not yet recruiting, Estimated PCD: 2025-07-01